Maglangit, Jay Lorenz G.
HRN: 10-81-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 1.5GM (VIAL)
02/28/2023
03/06/2023
IVT
900
Q8
ACUTE PYELONEPHRITIS
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes